Leonardo Biosystems (Houston, TX) a development-stage biopharmaceutical company focused on drug delivery technology, closed a $1.25M Series A financing, bringing the total round to $2.5M. Participants include Texas Emerging Technology Fund.

Inova Labs (Austin, TX) a medical device company focused on the development, manufacturing, and worldwide distribution of medical devices used to treat Chronic Obstructive Pulmonary Disease, closed a $17.5 million in Series B financing. Participants include Latterell Venture Partners, Gilde Healthcare Partners and Three Arch Partners.

Affinium Pharmaceuticals (Austin, TX) a clinical-stage specialty pharmaceutical company focused on small molecule antibiotics targeting staph and MRSA infections, closed a $15M Series B financing. Participants include SV Life Sciences, Genesis Capital Partners, Forward Ventures and Ontario Emerging Technologies Fund.
Thanx for your patience as we catch-up.

Teladoc (Dallas, TX) a commercial-stage on-demand telehealth services provider, closed a $18.6M Series D financing. Participants include Kleiner Perkins, Cardinal Partners, HLM Venture Partners, Trident Capital and New Capital Partners.

ViroXis (San Antonio, TX) a development stage biopharmaceutical company focused on antiviral treatment of HPV associated skin warts, closed a $2.5M Series A financing. Participants include Texas Emerging Technology Fund.

IDEV Technologies (Webster, TX) a clinical-stage medical device company focused on endovascular and interventional stents, closed a $46M Series D financing. Participants include Piper Jaffray, PTV Sciences, Bay City Capital, RiverVest Venture Partners and Heron Capital.

Ortho Kinematics (Austin, TX) development-stage medical device spine diagnostics company focused on inter-vertebral motion analysis, closed a $2M Series B financing. Participants include Texo Ventures, PTV Sciences and Gatebridge Investments.

Reata Pharmaceuticals (Irving, TX) a clinical-stage small molecule company focused on inflammation modulation in chronic kidney disease, closed a $78M Series D financing. Participants include CPMG and Novo Ventures.

Ensysce Biosciences (Houston, TX) a development-stage biopharma company focused on carbon nanotube complexes for chemotherapeutic transport, closed a $1.5M Series A financing. Participants include Texas Emerging Technology Fund.

Palmaz Scientific (Dallas, TX) a development-stage nano-biomaterials company focused on a vapor deposition process to increase the reliability of implantable prosthetic devices, closed a $3M Series A financing. Participants include Texas Emerging Technology Fund.

TVA Medical (Austin, TX) a development-stage medical device company focused on a minimally invasive approach for the treatment of end-stage renal disease, closed a $2.6M Series A financing. Participants include Santé Ventures.

Savara Pharmaceuticals (Austin, TX) a development-stage Dry powder and nebulizer-based drug delivery solution, closed a $1.4M Series A financing. Participants were not identified.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb

Ortho Kinematics (Austin, TX) a development-stage spine diagnostics company focused on inter-vertebral motion analysis, closed a $2M Series A financing. Participants include PTV Sciences, Texas Emerging Technology Fund and Gatebridge Investments.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb